388 WEDNESDAY • MAY 18 P1062 P1063 Facilitator: P1064 P1065 P1066 P1067 P1068 Facilitator: P1069 P1070 P1071 P1072 D57 Does Hypoxia Only Importan for Fatty Liver in OSA Patients/B. Sertogullarindan, D. Bulut, H. Gunbatar, A. Sunnetcioglu, S. Ekin, A. Arisoy, Izmir, Turkey, p.A7441 Up-Regulation of Selenoprotein P and HIP/PAP in Hepatocytes by Cyclic Intermittent Hypoxia/H. Ota, M. Yamauchi, N. Koyama, Y. Fujita, A. Itaya-Hironaka, A. Yamauchi, S. Sakuramoto-Tshuchida, R. Shobatake, K. Tomoda, M. Yoshikawa, S. Takasawa, H. Kimura, Kashiara Nara, Japan, p.A7442 V.Y. Polotsky, MD, PhD, Baltimore, MD The Study of Serum Endoplasmic Reticulum Stress Protein (GRP78) in Obstructive Sleep Apnea/J. Han, W. Wang, Z. Jiang, J. Kang, Shenyang, China, p.A7443 The Changes of Urinary Lipocalin-Type Prostaglandin D Synthase After 3 Months CPAP Treatment in Obstructive Sleep Apnea Patients/J. Su, S. Ouyang, L. Sun, M. Wang, X. Ma, W. Wang, C. Zhao, Zheng Zhou, China, p.A7444 Plasma Concentration of Gelatinases and Their Inhibitors in Obstructive Sleep Apnea Syndrome/B. Canino, E. Hopps, V. Calandrino, C. Urso, R. Lo Presti, G. Caimi, Palermo, Italy, p.A7445 Sleep Disorders in Breast Cancer/S. Shafazand, M. Schweitzer, M. Lippman, Miami, FL, p.A7446 Cancer Prevalence and Intermittent Hypoxia in Obstructive Sleep Apnea/A. Cargill, R. ElYousef, M.R. Al-Ajam, M. Cutaia, Brooklyn, NY, p.A7447 C. Lal, MD, Charleston, SC Erythrocyte Sedimentation Rate May Help Predict Severity of Obstructive Seep Apnea/S.-N. Hong, H.J. Kim, W.H. Lee, Korea, Republic of, p.A7448 The Analysis of Pattern Visual Evoked Potential in Obstructive Sleep Apnea Syndrome/H. Huang, W. Wang, Shenyang City, China, p.A7449 Baseline Data from the ROSA Trial: A Randomised Controlled Trial of the Effect of CPAP on Diabetic Macular Oedema in People with Concurrent Obstructive Sleep Apnoea/S.D. West, J. Hughes, B. Prudon, Newcastle, United Kingdom, p.A7450 Various Types of Sleep Disordered Breathing Associated with Multiple System Atrophy/M. Yamauchi, Y. Fujita, H. Uyama, N. Koyama, M. Yoshikawa, H. Kimura, Kashihara, Japan, p.A7451 THEMATIC POSTER SESSION DON’T BE A DO-BADDER: NEW INTERVENTIONS FOR OSA 9:00 a.m. - 3:30 p.m. MOSCONE CENTER Viewing: Posters will be on display for entire session. Area J, Hall D (North Building, Lower Level) Discussion: 11:00-11:45: authors will be present for individual discussion 11:45-12:45: authors will be present for discussion with assigned facilitators Facilitator: P1074 P1075 P1076 P1077 Facilitator: P1078 P1079 P1080 P1081 P1082 Facilitator: P1083 P1084 R.J. Kimoff, MD, Montreal, Canada The Role of Volume Assured Pressure Support (AVAPS) in Patients with Amyotrophic Lateral Sclerosis: A Preliminary Report/L.M. Fontana, P. Barkhaus, A. Anton, Milwaukee, WI, p.A7452 Noninvasive Ventilation Efficacy for Obesity Hypoventilation Syndrome Without Severe Sleep Apnea/J.F. Masa, J. Corral, C. Caballero, E. Barrot, J. Teran-Santos, M.L. Alonso-Alvarez, T. Gomez-Garcia, M. Gonzalez, S. Lopez-Martinez, P. De Lucas, J.M. Marin, S. Marti, T. Diaz-Cambriles, E. Chiner, C. Egea, E. Miranda, B. Mokhlesi, Caceres, Spain, p.A7453 Low Flow Nasal Pillow Mask Meets CPAP Efficacy/P.N. DeYoung, J.E. Orr, Y. Li, A. Malhotra, La Jolla, CA, p.A7454 Effects of Nasal CPAP on Exhaled SIRT1 and Tumor Necrosis Factor-a in Patients with Obstructive Sleep Apnea/C.-C. Lin, C.-H. Chiu, S.-F. Liaw, New Taipei City, Taiwan, p.A7455 J.M. Coleman, MD, Chicago, IL The Role of Nasal Resistance in CPAP Adherence in the World Trade Center First Responder Cohort/P. Agarwala, E. Ducca, T. Gumb, A. Twumasi, K. Black, C. Lewis, S. Alimokhtari, A. Perez, S.-E. Lu, N. Chitkara, D. Harrison, I. Udasin, J. Sunderram, D. Rapoport, I.A. Ayappa, New York, NY, p.A7456 The Effects of Adding Heated Humidification to Nasopharynx on Nasal Resistance, Breathing Pattern, and Sympathetic Nerve Activity/Y. Fujita, M. Yamauchi, H. Oda, M. Igaki, M. Yoshikawa, H. Kimura, Kashihara, Japan, p.A7457 Decreased CPAP Adherence in Non-Obese OSA Patients with Reversible Upper Airway Obstruction/P.G. Belvitch, J. Doumit, I. Rubinstein, Chicago, IL, p.A7458 Determinant Factors of Discontinuation of Continuous Positive Airway Pressure Therapy in Patients with Obstructive Sleep Apnea Syndrome/K. Takeyama, M. Tsuji, H. Hara, A. Ichikawa, K. Orimo, R. Mizobuchi, T. Aizawa, C. Sugita, J. Nakata, J. Tamaoki, Tokyo, Japan, p.A7459 The Use of a Validated Claustrophobia Questionnaire in Predicting Future Compliance to Continuous Positive Airway Pressure (CPAP) in Obstructive Sleep Apnea (OSA)/M. Aljasmi, K. Agarwal, S. Uppalapati, K. Moss, L. Bazan, C. Drake, Detroit, MI, p.A7460 R. Arens, MD, Bronx, NY The Effect of Supplemental Oxygen in Obesity Hypoventilation Syndrome/M.-A. Sanchez-Quiroga, J.F. Masa, J. Corral, A. Romero, C. Caballero, J. Teran-Santos, M.L. Alonso-Alvarez, T. Gomez-Garcia, M. Gonzalez, S. Lopez-Martinez, P. De Lucas, J.M. Marin, S. Marti, T. Diaz-Cambriles, E. Chiner, M. Merchan, C. Egea, A. Obeso, B. Mokhlesi, Plasencia, Spain, p.A7461 Determination of the Fraction of Inspired Oxygen (Fi02) with Different Oxygen Flows and Different CPAP Levels in Domiciliary Noninvasive Ventilators (DNIV)/J.I. Marmolejo, R.E. Gutierrez, J. Leon, T. Cortes, C. Ortiz, V.P. Vergara, F.A. Salinas, M.F. Cerda, P.A. Villagran, N.S. Gonzalez, F.P. Riquelme, C. Merino, L.A. Soto, J.E. Keymer, J.L. Molina, Santiago, Chile, p.A7462 ATS 2016 • San Francisco
WEDNESDAY • MAY 18 389 P1085 P1086 The Relationship Between Weight Loss and Non-Supine Apnea-Hypopnea Index/S.A. Joosten, J.K. Khoo, J.B. Dixon, M.T. Naughton, B.A. Edwards, G.S. Hamilton, Melbourne, Australia, p.A7463 Evaluating the Use of Quality Care Measures in the Assessment and Management of Obstructive Sleep Apnea Patients/N. Uppal, C. Ryan, Toronto, Canada, p.A7464 Facilitator: P1087 P1088 P1089 Facilitator: P1090 P1091 P1092 P1093 P1094 J.E. Metz, DDS, Columbus, OH Effect of Positional Therapy on the Pharyngeal Structure Causing Collapse in Obstructive Sleep Apnea Patients/M. Marques, P. Genta, S.A. Sands, A. Azarbarzin, C.M. De Melo, L. Taranto Montemurro, D.P. White, A. Wellman, Boston, MA, p.A7465 Effects of Sleep Stage and Body Position on Snoring Severity/M. Guzman, F. Sgambati, H. Pho, R.S. Arias, T. Otvos, E. Wolfe, I. Hawks, J.P. Kirkness, H. Schneider, P.L. Smith, A.R. Schwartz, Baltimore, MD, p.A7466 Prediction of Outcome With Oral Appliance Therapy for Obstructive Sleep Apnea Using In-home Mandibular Titration/J. Remmers, Z. Topor, J. Grosse, N. Vranjes, S. Charkandeh, Calgary, Canada, p.A7467 S. Redolfi, MD, PhD, Paris, France Three Year Outcomes of Upper Airway Stimulation for Obstructive Sleep Apnea/P.J. Strollo, W. Randerath, K.P. Strohl, Pittsburgh, PA, p.A7468 Effect of Conversion from Conventional to Nocturnal Home Hemodialysis on Fluid Volume Status and Sleep Apnea Severity in End Stage Renal Disease/O. Lyons, T. Inami, A. Yadollahi, C.T. Chan, T.D. Bradley, Toronto, Canada, p.A7469 Effects of Fluid Removal by Ultrafiltration on Sleep Apnea Severity and Cardiac Function in End Stage Renal Disease/T. Inami, O. Lyons, A. Yadollahi, C.T. Chan, J.S. Floras, T.D. Bradley, Toronto, Canada, p.A7470 Effects of Melatonin Supplementation in Obstructive Sleep Apnea Patients/N.L. Deacon, E. Smales, R. Jen, S. Jaiswal, Y. Li, A. Malhotra, La Jolla, CA, p.A7471 The Effect of Donepezil on Sleep Apnea in Patients with Obstructive Sleep Apnea- a Randomized, Double Blind Cross-Over Study/Y. Li, R.L. Owens, S.A. Sands, J.E. Orr, P.N. DeYoung, E.T. Smales, R. Jen, A. Malhotra, La Jolla, CA, p.A7472 WS7 Wednesday Mid-day, May 18 CLINICAL WORKSHOP CME Credits Available: 1.5 UPDATE ON EBUS: PRACTICAL QUESTIONS ANSWERED Registration Fee: $75.00 (includes box lunch) Attendance is limited. Pre-registration is required. Assemblies on Clinical Problems; Thoracic Oncology 11:45 a.m. - 1:15 p.m. MOSCONE CENTER Room 301 (South Building, Esplanade Level) Target Audience Providers of lung health;practitioners who perform or who are interested in bronchoscopy and EBUS; physicians-in-training. Objectives At the conclusion of this session, the participant will be able to: • identify the indications and diagnostic yield of EBUS; • understand the various factors that can affect diagnostic yield, safety and efficiency of EBUS; • apply the information learned to plan an optimal EBUS procedure with consideration of the various equipment and support available. Endobronchial ultrasound (EBUS) was introduced in the last decade, enabling real-time guidance of transbronchial needle aspiration (TBNA) of mediastinal and hilar structures and parabronchial lung masses. Many publications about EBUS-TBNA have led to a better understanding of the performance characteristics of this procedure. The goal of this workshop is to examine the current literature on the practical aspects of EBUS-TBNA to provide evidence-based and expert guidance to clinicians. Chairing: A.C. Argento, MD, Chicago, IL M.M. Wahidi, MD, Durham, NC C.T. Gillespie, MD, Chicago, IL H. Lee, MD, Baltimore, MD WEDNESDAY MID-DAY The information contained in this program is up to date as of March 9, 2016. For the most current session information, please visit the online program itinerary. ATS 2016 • San Francisco
- Page 1 and 2:
American Thoracic Society Internati
- Page 3:
TABLE OF CONTENTS ATS 2016 INTERNAT
- Page 6 and 7:
2 FRIDAY • MAY 13 PG2A CLINICAL P
- Page 8 and 9:
4 FRIDAY • MAY 13 Target Audience
- Page 10 and 11:
6 FRIDAY • MAY 13 11:15 Case Disc
- Page 12 and 13:
8 FRIDAY • MAY 13 Chairing: H.B.
- Page 14 and 15:
10 FRIDAY • MAY 13 10:25 Advanced
- Page 16 and 17:
12 FRIDAY • MAY 13 Objectives At
- Page 18 and 19:
14 SATURDAY • MAY 14 Abdominal Ul
- Page 20 and 21:
16 SATURDAY • MAY 14 PG17 BASIC
- Page 22 and 23:
18 SATURDAY • MAY 14 1:05 In What
- Page 24 and 25:
20 SATURDAY • MAY 14 10:30 Practi
- Page 26 and 27:
22 SATURDAY • MAY 14 Objectives A
- Page 28 and 29:
24 SATURDAY • MAY 14 10:10 Is My
- Page 30 and 31:
26 SUNDAY • MAY 15 Chairing: D.M.
- Page 32 and 33:
28 SUNDAY • MAY 15 Chronic Cough:
- Page 34 and 35:
30 SUNDAY • MAY 15 • understand
- Page 36 and 37:
32 SUNDAY • MAY 15 Target Audienc
- Page 38 and 39:
34 SUNDAY • MAY 15 Oral Presentat
- Page 40 and 41:
36 SUNDAY • MAY 15 9:15 Hyperpola
- Page 42 and 43:
38 SUNDAY • MAY 15 310 A Smartpho
- Page 44 and 45:
40 SUNDAY • MAY 15 103 Immunosupp
- Page 46 and 47:
42 SUNDAY • MAY 15 A26 POSTER DIS
- Page 48 and 49:
44 SUNDAY • MAY 15 822 Incidence
- Page 50 and 51:
46 SUNDAY • MAY 15 519 Maternal H
- Page 52 and 53:
48 SUNDAY • MAY 15 P14 P15 P16 P1
- Page 54 and 55:
50 SUNDAY • MAY 15 P1545 P1546 Fa
- Page 56 and 57:
52 SUNDAY • MAY 15 P60 P61 Facili
- Page 58 and 59:
54 SUNDAY • MAY 15 P149 P150 Faci
- Page 60 and 61:
56 SUNDAY • MAY 15 P749 P750 P751
- Page 62 and 63:
58 SUNDAY • MAY 15 Facilitator: P
- Page 64 and 65:
60 SUNDAY • MAY 15 P1243 P1244 P1
- Page 66 and 67:
62 SUNDAY • MAY 15 P1295 P1296 P1
- Page 68 and 69:
64 SUNDAY • MAY 15 P1358 P1359 P1
- Page 70 and 71:
66 SUNDAY • MAY 15 P91 Facilitato
- Page 72 and 73:
68 SUNDAY • MAY 15 P616 P617 P618
- Page 74 and 75:
70 SUNDAY • MAY 15 P914 P915 P916
- Page 76 and 77:
72 SUNDAY • MAY 15 P556 P557 P558
- Page 78 and 79:
74 SUNDAY • MAY 15 Facilitators:
- Page 80 and 81:
76 SUNDAY • MAY 15 P997 P998 P999
- Page 82 and 83:
78 SUNDAY • MAY 15 P256 P257 P258
- Page 84 and 85:
80 SUNDAY • MAY 15 A61 THEMATIC P
- Page 86 and 87:
82 SUNDAY • MAY 15 P824 Facilitat
- Page 88 and 89:
84 SUNDAY • MAY 15 P1055 P1056 P1
- Page 90 and 91:
86 SUNDAY • MAY 15 P1101 P1102 P1
- Page 92 and 93:
88 SUNDAY • MAY 15 P1423 P1424 P1
- Page 94 and 95:
90 SUNDAY • MAY 15 P1474 P1475 P1
- Page 96 and 97:
92 SUNDAY • MAY 15 P377 P378 P379
- Page 98 and 99:
94 SUNDAY • MAY 15 P281 P282 P283
- Page 100 and 101:
96 SUNDAY • MAY 15 P450 P451 A74
- Page 102 and 103:
98 SUNDAY • MAY 15 P1562 P1563 P1
- Page 104 and 105:
100 SUNDAY • MAY 15 A80-A THEMATI
- Page 106 and 107:
102 SUNDAY • MAY 15 Facilitator:
- Page 108 and 109:
104 SUNDAY • MAY 15 11:00 a.m.-12
- Page 110 and 111:
106 SUNDAY • MAY 15 L1 U.S. FOOD
- Page 112 and 113:
108 SUNDAY • MAY 15 12:15 Post-Pr
- Page 114 and 115:
110 SUNDAY • MAY 15 MP406 MP407 M
- Page 116 and 117:
112 SUNDAY • MAY 15 clinician and
- Page 118 and 119:
114 SUNDAY • MAY 15 A86 BASIC •
- Page 120 and 121:
116 SUNDAY • MAY 15 Chairing: M.J
- Page 122 and 123:
118 SUNDAY • MAY 15 3:30 High Pre
- Page 124 and 125:
120 SUNDAY • MAY 15 102 Toll-Like
- Page 126 and 127:
122 SUNDAY • MAY 15 A103 POSTER D
- Page 128 and 129:
124 SUNDAY • MAY 15 719 Lactate R
- Page 130 and 131:
126 SUNDAY • MAY 15 1014 Determin
- Page 132 and 133:
128 SUNDAY • MAY 15 611 Plasma Mi
- Page 134 and 135:
130 SUNDAY • MAY 15 412 Daytime S
- Page 136 and 137:
132 SUNDAY • MAY 15 6:30 p.m. - 8
- Page 138 and 139:
134 MONDAY • MAY 16 SS111 SS112 S
- Page 140 and 141:
136 MONDAY • MAY 16 Target Audien
- Page 142 and 143:
138 MONDAY • MAY 16 9:40 Empoweri
- Page 144 and 145:
140 MONDAY • MAY 16 9:28 Endotoxi
- Page 146 and 147:
142 MONDAY • MAY 16 10:15 Adaptiv
- Page 148 and 149:
144 MONDAY • MAY 16 Oral Presenta
- Page 150 and 151:
146 MONDAY • MAY 16 624 Neonatal
- Page 152 and 153:
148 MONDAY • MAY 16 118 Compariso
- Page 154 and 155:
150 MONDAY • MAY 16 912 Should Pa
- Page 156 and 157:
152 MONDAY • MAY 16 1015 Resverat
- Page 158 and 159:
154 MONDAY • MAY 16 718 Health Re
- Page 160 and 161:
156 MONDAY • MAY 16 P152 Facilita
- Page 162 and 163:
158 MONDAY • MAY 16 B35 THEMATIC
- Page 164 and 165:
160 MONDAY • MAY 16 P252 P253 P25
- Page 166 and 167:
162 MONDAY • MAY 16 P406 P407 P40
- Page 168 and 169:
164 MONDAY • MAY 16 P320 Bilatera
- Page 170 and 171:
166 MONDAY • MAY 16 B40 THEMATIC
- Page 172 and 173:
168 MONDAY • MAY 16 P528 P529 Fac
- Page 174 and 175:
170 MONDAY • MAY 16 Facilitator:
- Page 176 and 177:
172 MONDAY • MAY 16 B44 THEMATIC
- Page 178 and 179:
174 MONDAY • MAY 16 P484 P485 P48
- Page 180 and 181:
176 MONDAY • MAY 16 P1161 P1162 P
- Page 182 and 183:
178 MONDAY • MAY 16 B48 THEMATIC
- Page 184 and 185:
180 MONDAY • MAY 16 P1238 P1239 P
- Page 186 and 187:
182 MONDAY • MAY 16 P1297 P1298 P
- Page 188 and 189:
184 MONDAY • MAY 16 Facilitator:
- Page 190 and 191:
186 MONDAY • MAY 16 P15 P16 P17 P
- Page 192 and 193:
188 MONDAY • MAY 16 Facilitator:
- Page 194 and 195:
190 MONDAY • MAY 16 P114 P115 P11
- Page 196 and 197:
192 MONDAY • MAY 16 P1408 Enhance
- Page 198 and 199:
194 MONDAY • MAY 16 P1455 P1456 P
- Page 200 and 201:
196 MONDAY • MAY 16 P1487 P1488 P
- Page 202 and 203:
198 MONDAY • MAY 16 P1514 P1515 P
- Page 204 and 205:
200 MONDAY • MAY 16 Facilitator:
- Page 206 and 207:
202 MONDAY • MAY 16 P559 P560 P56
- Page 208 and 209:
204 MONDAY • MAY 16 WS3 CLINICAL
- Page 210 and 211:
206 MONDAY • MAY 16 Satellite ear
- Page 212 and 213:
208 MONDAY • MAY 16 Objectives At
- Page 214 and 215:
210 MONDAY • MAY 16 encourage tra
- Page 216 and 217:
212 MONDAY • MAY 16 B82 BEHAVIORA
- Page 218 and 219:
214 MONDAY • MAY 16 B86 BASIC •
- Page 220 and 221:
216 MONDAY • MAY 16 and a number
- Page 222 and 223:
218 MONDAY • MAY 16 2:30 Mortalit
- Page 224 and 225:
220 MONDAY • MAY 16 3:00 Simultan
- Page 226 and 227:
222 MONDAY • MAY 16 525 Clinical
- Page 228 and 229:
224 MONDAY • MAY 16 320 Sensitivi
- Page 230 and 231:
226 MONDAY • MAY 16 113 COPD Subt
- Page 232 and 233:
228 MONDAY • MAY 16 1004 Health C
- Page 234 and 235:
230 MONDAY • MAY 16 609 Skeletal
- Page 236 and 237:
232 MONDAY • MAY 16 5:00 p.m. - 7
- Page 238 and 239:
234 TUESDAY • MAY 17 Chairing: D.
- Page 240 and 241:
236 TUESDAY • MAY 17 CLINICAL YEA
- Page 242 and 243:
238 TUESDAY • MAY 17 This session
- Page 244 and 245:
240 TUESDAY • MAY 17 bronchiectas
- Page 246 and 247:
242 TUESDAY • MAY 17 Target Audie
- Page 248 and 249:
244 TUESDAY • MAY 17 C18 MINI SYM
- Page 250 and 251:
246 TUESDAY • MAY 17 415 Investig
- Page 252 and 253:
248 TUESDAY • MAY 17 207 Survival
- Page 254 and 255:
250 TUESDAY • MAY 17 906 Phenotyp
- Page 256 and 257:
252 TUESDAY • MAY 17 807 The Vali
- Page 258 and 259:
254 TUESDAY • MAY 17 515 Roles of
- Page 260 and 261:
256 TUESDAY • MAY 17 P383 P384 P3
- Page 262 and 263:
258 TUESDAY • MAY 17 Facilitator:
- Page 264 and 265:
260 TUESDAY • MAY 17 P199 P200 P2
- Page 266 and 267:
262 TUESDAY • MAY 17 P620 Facilit
- Page 268 and 269:
264 TUESDAY • MAY 17 P428 P429 P4
- Page 270 and 271:
266 TUESDAY • MAY 17 P442 P443 P4
- Page 272 and 273:
268 TUESDAY • MAY 17 P318 P319 P3
- Page 274 and 275:
270 TUESDAY • MAY 17 P474 P475 Fa
- Page 276 and 277:
272 TUESDAY • MAY 17 Facilitator:
- Page 278 and 279:
274 TUESDAY • MAY 17 P727 P728 P7
- Page 280 and 281:
276 TUESDAY • MAY 17 P774 P775 Fa
- Page 282 and 283:
278 TUESDAY • MAY 17 C53 THEMATIC
- Page 284 and 285:
280 TUESDAY • MAY 17 C55 THEMATIC
- Page 286 and 287:
282 TUESDAY • MAY 17 P1095 P1096
- Page 288 and 289:
284 TUESDAY • MAY 17 P1167 P1168
- Page 290 and 291:
286 TUESDAY • MAY 17 P632 P633 P6
- Page 292 and 293:
288 TUESDAY • MAY 17 P546 P547 P5
- Page 294 and 295:
290 TUESDAY • MAY 17 Facilitator:
- Page 296 and 297:
292 TUESDAY • MAY 17 C65 THEMATIC
- Page 298 and 299:
294 TUESDAY • MAY 17 P659 P660 P6
- Page 300 and 301:
296 TUESDAY • MAY 17 P1506 P1507
- Page 302 and 303:
298 TUESDAY • MAY 17 C70 THEMATIC
- Page 304 and 305:
300 TUESDAY • MAY 17 P1363 P1364
- Page 306 and 307:
302 TUESDAY • MAY 17 P928 P929 P9
- Page 308 and 309:
304 TUESDAY • MAY 17 P973 P974 Fa
- Page 310 and 311:
306 TUESDAY • MAY 17 Facilitator:
- Page 312 and 313:
308 TUESDAY • MAY 17 C80 THEMATIC
- Page 314 and 315:
310 TUESDAY • MAY 17 P98 P99 P100
- Page 316 and 317:
312 TUESDAY • MAY 17 • become a
- Page 318 and 319:
314 TUESDAY • MAY 17 The topics a
- Page 320 and 321:
316 TUESDAY • MAY 17 C85 BASIC
- Page 322 and 323:
318 TUESDAY • MAY 17 C89 BASIC
- Page 324 and 325:
320 TUESDAY • MAY 17 3:20 Pediatr
- Page 326 and 327:
322 TUESDAY • MAY 17 2:45 Long-Te
- Page 328 and 329:
324 TUESDAY • MAY 17 918 Sarcoido
- Page 330 and 331:
326 TUESDAY • MAY 17 410 Effectiv
- Page 332 and 333:
328 TUESDAY • MAY 17 710 Follista
- Page 334 and 335:
330 TUESDAY • MAY 17 509 A Mechan
- Page 336 and 337:
332 TUESDAY • MAY 17 806 Upper Ai
- Page 338 and 339:
334 WEDNESDAY • MAY 18 6:45 Acute
- Page 340 and 341:
336 WEDNESDAY • MAY 18 CLINICAL Y
- Page 342 and 343: 338 WEDNESDAY • MAY 18 Objectives
- Page 344 and 345: 340 WEDNESDAY • MAY 18 D9 BASIC
- Page 346 and 347: 342 WEDNESDAY • MAY 18 Oral Prese
- Page 348 and 349: 344 WEDNESDAY • MAY 18 10:15 Plas
- Page 350 and 351: 346 WEDNESDAY • MAY 18 419 A Nove
- Page 352 and 353: 348 WEDNESDAY • MAY 18 216 Simpli
- Page 354 and 355: 350 WEDNESDAY • MAY 18 815 Multip
- Page 356 and 357: 352 WEDNESDAY • MAY 18 D28 POSTER
- Page 358 and 359: 354 WEDNESDAY • MAY 18 720 Repeat
- Page 360 and 361: 356 WEDNESDAY • MAY 18 P389 Facil
- Page 362 and 363: 358 WEDNESDAY • MAY 18 P439 P440
- Page 364 and 365: 360 WEDNESDAY • MAY 18 P10 P11 P1
- Page 366 and 367: 362 WEDNESDAY • MAY 18 P52 P53 Fa
- Page 368 and 369: 364 WEDNESDAY • MAY 18 P95 P96 P9
- Page 370 and 371: 366 WEDNESDAY • MAY 18 P698 P699
- Page 372 and 373: 368 WEDNESDAY • MAY 18 D42 THEMAT
- Page 374 and 375: 370 WEDNESDAY • MAY 18 P748 Funge
- Page 376 and 377: 372 WEDNESDAY • MAY 18 P353 P354
- Page 378 and 379: 374 WEDNESDAY • MAY 18 P172 P173
- Page 380 and 381: 376 WEDNESDAY • MAY 18 P808 Facil
- Page 382 and 383: 378 WEDNESDAY • MAY 18 P526 P527
- Page 384 and 385: 380 WEDNESDAY • MAY 18 P579 P580
- Page 386 and 387: 382 WEDNESDAY • MAY 18 P944 P945
- Page 388 and 389: 384 WEDNESDAY • MAY 18 P991 P992
- Page 390 and 391: 386 WEDNESDAY • MAY 18 P1036 P103
- Page 394 and 395: 390 WEDNESDAY • MAY 18 11:45 Intr
- Page 396 and 397: 392 WEDNESDAY • MAY 18 12:15 Upda
- Page 398 and 399: 394 WEDNESDAY • MAY 18 This sessi
- Page 400 and 401: 396 WEDNESDAY • MAY 18 1:30 The B
- Page 402 and 403: 398 WEDNESDAY • MAY 18 D88 BEHAVI
- Page 404 and 405: 400 WEDNESDAY • MAY 18 3:00 Accel
- Page 406 and 407: 402 WEDNESDAY • MAY 18 D96 MINI S
- Page 408 and 409: 404 WEDNESDAY • MAY 18 604 CARMA3
- Page 410 and 411: 406 WEDNESDAY • MAY 18 702 Potent
- Page 412 and 413: 408 WEDNESDAY • MAY 18 803 ICU Ac
- Page 414 and 415: 410 WEDNESDAY • MAY 18 Chairing:
- Page 416 and 417: 412 WEDNESDAY • MAY 18 404 Interm
- Page 418: Where today’s science meets tomor